Pope JE - Search Results

1

A randomized trial of arthroscopic surgery for osteoarthritis of the knee.

Kirkley A, Birmingham TB, Litchfield RB, Giffin JR, Willits KR, Wong CJ, Feagan BG, Donner A, Griffin SH, D'Ascanio LM, Pope JE, Fowler PJ. Kirkley A, et al. Among authors: pope je. N Engl J Med. 2008 Sep 11;359(11):1097-107. doi: 10.1056/NEJMoa0708333. N Engl J Med. 2008. PMID: 18784099 Free article. Clinical Trial.

2

A randomized double blind trial of verbal NSAID education compared to verbal and written education.

Pope JE, Stevens A, Rooks M. Pope JE, et al. J Rheumatol. 1998 Apr;25(4):771-5. J Rheumatol. 1998. PMID: 9558184 Clinical Trial.

3

A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.

Pope JE, Bellamy N, Seibold JR, Baron M, Ellman M, Carette S, Smith CD, Chalmers IM, Hong P, O'Hanlon D, Kaminska E, Markland J, Sibley J, Catoggio L, Furst DE. Pope JE, et al. Arthritis Rheum. 2001 Jun;44(6):1351-8. doi: 10.1002/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I. Arthritis Rheum. 2001. PMID: 11407694 Free article. Clinical Trial.

4

Treatment of osteoarthritis of the hip and knee: a comparison of NSAID use in patients for whom surgery was and was not recommended.

Pope JE, McCrea K, Stevens A, Ouimet JM. Pope JE, et al. Clin Exp Rheumatol. 2004 Mar-Apr;22(2):171-6. Clin Exp Rheumatol. 2004. PMID: 15083884

5

Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis.

Cibere J, Kopec JA, Thorne A, Singer J, Canvin J, Robinson DB, Pope J, Hong P, Grant E, Esdaile JM. Cibere J, et al. Arthritis Rheum. 2004 Oct 15;51(5):738-45. doi: 10.1002/art.20697. Arthritis Rheum. 2004. PMID: 15478160 Free article. Clinical Trial.

6

Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.

Cibere J, Thorne A, Kopec JA, Singer J, Canvin J, Robinson DB, Pope J, Hong P, Grant E, Lobanok T, Ionescu M, Poole AR, Esdaile JM. Cibere J, et al. J Rheumatol. 2005 May;32(5):896-902. J Rheumatol. 2005. PMID: 15868627 Clinical Trial.

7

Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis.

Thompson AE, Shea B, Welch V, Fenlon D, Pope JE. Thompson AE, et al. Among authors: pope je. Arthritis Rheum. 2001 Aug;44(8):1841-7. doi: 10.1002/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8. Arthritis Rheum. 2001. PMID: 11508437 Free article.

8

The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma.

Sultan N, Pope JE, Clements PJ; Scleroderma Trials Study Group. Sultan N, et al. Among authors: pope je. Rheumatology (Oxford). 2004 Apr;43(4):472-8. doi: 10.1093/rheumatology/keh070. Epub 2003 Dec 16. Rheumatology (Oxford). 2004. PMID: 14679295 Clinical Trial.

9

Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials.

Yuen SY, Pope JE. Yuen SY, et al. Among authors: pope je. Rheumatology (Oxford). 2008 Sep;47(9):1367-72. doi: 10.1093/rheumatology/ken230. Epub 2008 Jun 24. Rheumatology (Oxford). 2008. PMID: 18577549 Review.

10

The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.

Sekhon S, Pope J; Canadian Scleroderma Research Group; Baron M. Sekhon S, et al. J Rheumatol. 2010 Mar;37(3):591-8. doi: 10.3899/jrheum.090375. Epub 2010 Jan 15. J Rheumatol. 2010. PMID: 20080913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

478 results

Search Page